Volitionrx Ltd (VNRX) Stock Price, Quote & News

Company Profile

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progre...

Industry: Medical Devices

Sector: Healthcare

Phone: 646 650 1351

Website: volition.com

Address:

1489 West Warm Springs Road, Suite 110, Henderson, United States

Love_To_Learn Oct. 29 at 10:33 PM

$VNRX u have been delayed on your movement and r 5 days behind on purpose that will play catch up starting tomo on your pacing

0 · Reply

coldfacts Oct. 27 at 3:14 PM

$VNRX added some here

0 · Reply

Bocholter Oct. 24 at 7:33 PM

$VNRX buy buy buy🥳

1 · Reply

vinkush1 Oct. 24 at 7:30 PM

$VNRX finally getting the pump it deserves ⁉️

2 · Reply

Bocholter Oct. 24 at 7:29 PM

$VNRX Short sellers. Think about your money ;). Especially if you have a family.

1 · Reply

Bocholter Oct. 24 at 7:25 PM

$VNRX so Ladies. An Info for all the shorties…..it will be hot tonight🔥🔥🔥🥳

1 · Reply

Kululu Oct. 23 at 8:03 PM

$VNRX why this crap moves after hours and goes back to same shtty level again

0 · Reply

2021er Oct. 23 at 2:55 PM

$VNRX bought more

1 · Reply

MeetyaMaker Oct. 23 at 10:07 AM

$VNRX sold my position at 0.49, phew

1 · Reply

XProfessorGamma Oct. 22 at 9:26 PM

How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $VNRX $HKIT $SUIG $BMEA Watchlist \

0 · Reply

Volition Donates Nu.Q® Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs

Oct 10, 2025, 8:30 AM EDT - 23 days ago

VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants

Oct 9, 2025, 4:05 PM EDT - 23 days ago

VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants

Oct 8, 2025, 4:56 PM EDT - 24 days ago

VolitionRx Limited - Special Call

Oct 2, 2025, 8:45 AM EDT - 4 weeks ago

Volition Sponsors Upcoming GenomeWeb Webinar

Sep 29, 2025, 9:30 AM EDT - 4 weeks ago

Volition Signs Co-Marketing and Services Agreement with Hologic

HOLX

Sep 9, 2025, 8:45 AM EDT - 7 weeks ago

Volition Signs First Human Out Licensing Deal

Aug 15, 2025, 2:24 PM EDT - 2 months ago

VolitionRx Limited (VNRX) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 4:10 PM EDT - 2 months ago

VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update

Aug 8, 2025, 8:30 AM EDT - 3 months ago

VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update

Aug 4, 2025, 4:01 PM EDT - 3 months ago

VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering

Jul 16, 2025, 8:00 AM EDT - 3 months ago

Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation

Jul 8, 2025, 8:00 AM EDT - 4 months ago

Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes

Jun 12, 2025, 8:30 AM EDT - 5 months ago

Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure

Jun 4, 2025, 9:00 PM EDT - 5 months ago

Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties

May 19, 2025, 8:30 AM EDT - 5 months ago

VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats

May 16, 2025, 7:19 PM EDT - 6 months ago

VolitionRX Limited (VNRX) Q1 2025 Earnings Call Transcript

May 15, 2025, 5:37 PM EDT - 6 months ago

VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update

May 12, 2025, 8:30 AM EDT - 6 months ago

VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update

May 7, 2025, 8:30 AM EDT - 6 months ago

VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q® NETs test adoption

Apr 29, 2025, 8:30 AM EDT - 6 months ago

VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets

Apr 1, 2025, 12:31 AM EDT - 7 months ago

VolitionRx Limited (VNRX) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:05 PM EDT - 7 months ago

VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update

Mar 28, 2025, 8:00 AM EDT - 7 months ago

Volition Announces Two Poster Presentations at ESMO's European Lung Cancer Congress 2025

Mar 27, 2025, 8:30 AM EDT - 7 months ago

Volition to Host Virtual Investor Event on Nu.Q® Cancer, "A Look to the Future of Cancer Diagnostics", on April 9, 2025

Mar 26, 2025, 8:00 AM EDT - 7 months ago

VolitionRx Announces Pricing of up to $2.3 Million Registered Direct Offering

Mar 25, 2025, 9:30 AM EDT - 7 months ago

VolitionRx Limited Schedules Full Fiscal Year 2024 Earnings Conference Call and Business Update

Mar 21, 2025, 8:30 AM EDT - 8 months ago

Volition's Nu.Q® Cancer Diagnostics Test Aims To Disrupt the Multi-Billion Dollar Liquid Biopsy Industry

Mar 20, 2025, 8:30 AM EDT - 8 months ago

Volition Introduces Nu.Q® Cancer Blood Test in New Industry Primer for Lung Cancer

Mar 17, 2025, 8:30 AM EDT - 8 months ago

Volition Proudly Sponsors the 44th ISICEM Congress

Mar 13, 2025, 8:30 AM EDT - 8 months ago

Volition Signs first ever Nu.Q® Vet Cancer Test Automation Agreement with Fujifilm Vet Systems

Mar 11, 2025, 8:30 AM EDT - 8 months ago

Volition Announces First Patient Enrolled in NTU Hospital's Prospective Validation Study of Nu.Q® Lung Cancer Test

Mar 4, 2025, 8:30 AM EST - 8 months ago

Volition's Nu.Q® Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time

Feb 28, 2025, 8:30 AM EST - 8 months ago

Volition Showcases Nu.Q® Vet Cancer Test at the 97th WVC Annual Conference

Feb 6, 2025, 8:30 AM EST - 9 months ago

Volition Signs First Commercial Project Utilizing Rapid High-Throughput Model in the Study of NETosis

Feb 5, 2025, 9:15 AM EST - 9 months ago

Volition to Host Virtual Investor Event on Nu.Q® NETs, "Casting a New Light on Sepsis Management", on February 14, 2025

Jan 30, 2025, 8:30 AM EST - 9 months ago

Large clinical study establishes Nu.Q® NETs H3.1 as an independent predictor of 28-day mortality in sepsis

Jan 8, 2025, 8:30 AM EST - 10 months ago

Volition Issues Business Review 2024

Dec 12, 2024, 8:00 AM EST - 11 months ago

VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants

Dec 10, 2024, 8:00 AM EST - 11 months ago

Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening

Dec 6, 2024, 9:00 AM EST - 11 months ago

VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering

Nov 15, 2024, 11:47 AM EST - 1 year ago

VolitionRx Limited (VNRX) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:10 PM EST - 1 year ago

VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update

Nov 8, 2024, 8:00 AM EST - 1 year ago

VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update

Nov 6, 2024, 4:10 PM EST - 1 year ago

Volition Appoints Timothy I. Still as Chairman

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating

Oct 9, 2024, 8:00 AM EDT - 1 year ago

Volition to share new 'NETs in sepsis management' data insights at upcoming webinar

Oct 3, 2024, 8:00 AM EDT - 1 year ago

Volition hosts NETs in sepsis management symposium at ESICM Lives 2024

Sep 30, 2024, 4:10 PM EDT - 1 year ago

Volition Appoints Dr. Ethel Rubin as an Independent Director

Sep 11, 2024, 8:00 AM EDT - 1 year ago

Volition Hosts KOL Roundtable on Sepsis

Love_To_Learn Oct. 29 at 10:33 PM

$VNRX u have been delayed on your movement and r 5 days behind on purpose that will play catch up starting tomo on your pacing

0 · Reply

coldfacts Oct. 27 at 3:14 PM

$VNRX added some here

0 · Reply

Bocholter Oct. 24 at 7:33 PM

$VNRX buy buy buy🥳

1 · Reply

vinkush1 Oct. 24 at 7:30 PM

$VNRX finally getting the pump it deserves ⁉️

2 · Reply

Bocholter Oct. 24 at 7:29 PM

$VNRX Short sellers. Think about your money ;). Especially if you have a family.

1 · Reply

Bocholter Oct. 24 at 7:25 PM

$VNRX so Ladies. An Info for all the shorties…..it will be hot tonight🔥🔥🔥🥳

1 · Reply

Kululu Oct. 23 at 8:03 PM

$VNRX why this crap moves after hours and goes back to same shtty level again

0 · Reply

2021er Oct. 23 at 2:55 PM

$VNRX bought more

1 · Reply

MeetyaMaker Oct. 23 at 10:07 AM

$VNRX sold my position at 0.49, phew

1 · Reply

XProfessorGamma Oct. 22 at 9:26 PM

How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $VNRX $HKIT $SUIG $BMEA Watchlist \

0 · Reply

RiseAndRiseAgain Oct. 22 at 6:31 PM

$VNRX I’m out. Didn’t make the upturn I was hoping for.

0 · Reply

Kululu Oct. 22 at 5:30 PM

$VNRX this ceo is so weak. He buys shares like retailers. He does not have confidence in his company .

0 · Reply

SingleCellOrganism Oct. 21 at 9:28 PM

$VNRX double the average daily volume. I’m in at .4438. Let’s see what happens

1 · Reply

Kululu Oct. 21 at 9:03 PM

$VNRX it looks like a bad stock. No upward trend is showing

0 · Reply

sn0wball Oct. 17 at 1:13 PM

$VNRX https://www.prnewswire.com/news-releases/volition-donates-nuq-vet-cancer-tests-to-hope-animal-assisted-crisis-response-dogs-302587549.html

1 · Reply

Kululu Oct. 16 at 4:22 PM

$VNRX too Much selling pressure

0 · Reply

2021er Oct. 16 at 3:18 PM

$VNRX

0 · Reply

Kululu Oct. 16 at 3:08 PM

$VNRX everytine when it tries to move up someone dumps a bunch of shares to pull it down

1 · Reply

SkinnyDude911 Oct. 16 at 2:26 PM

$VNRX strong volume. Some got pissed at the offering and I wasn't happy with it but I added 2000 more shares at .44 as this is going to see 60s again I think . Insiders loading . Feels like They shaking the dead money out.

0 · Reply

Laurapicksright Oct. 16 at 2:06 PM

$VNRX Insiders loaded $5PT could be next $MIRA $VIVK 😍😍

0 · Reply

RobbysInvestmentLLC Oct. 16 at 1:52 PM

$VNRX volume on the daily breakout off $MIRA

0 · Reply

Laurapicksright Oct. 16 at 1:50 PM

$VNRX can go parabolic here insiders been loading with $5PT lets break .50 same setup as $MIRA $VIVK $SCNX $WHWK 😍😍😍

0 · Reply

Market Cap	46.70M
Revenue (ttm)	1.23M
Net Income (ttm)	-26.97M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,192.68%
Debt to Equity Ratio	-0.21

Volume	501,700
Avg Vol	568,342
Day's Range	N/A - N/A
Shares Out	107.60M
Stochastic %K	34%
Beta	1.27
Analysts	Strong Sell
Price Target	$3.09